SCHORNO DEAN L (EVP &Chief Financial Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/12/2026ACC: 0000905148-26-000678
Officer· EVP &Chief Financial Officer
Since Jan 2019
-3.55K
Net shares
Net seller
$122.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.55K
Price / share
$34.62
Trade value
$122.76K
% of position
6.0%
2/10/2026
59.25K→55.70K
Total
Net shares
−3.55K
Net value
-$122.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −3.55K | $34.62 | $122.76K | 6.0% | 59.25K | 55.70K |
| Total | −3.55K | -$122.76K | ||||||
Derivative Transactions0
No derivative transactions reported